These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21029259)

  • 1. Sialoadenitis secondary to ¹³¹I therapy for well-differentiated thyroid cancer.
    Van Nostrand D
    Oral Dis; 2011 Mar; 17(2):154-61. PubMed ID: 21029259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?
    Nakada K; Ishibashi T; Takei T; Hirata K; Shinohara K; Katoh S; Zhao S; Tamaki N; Noguchi Y; Noguchi S
    J Nucl Med; 2005 Feb; 46(2):261-6. PubMed ID: 15695785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Radioiodine Treatment on Salivary Gland Function in Patients with Differentiated Thyroid Carcinoma: A Prospective Study.
    Klein Hesselink EN; Brouwers AH; de Jong JR; van der Horst-Schrivers AN; Coppes RP; Lefrandt JD; Jager PL; Vissink A; Links TP
    J Nucl Med; 2016 Nov; 57(11):1685-1691. PubMed ID: 27339871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermediate and long-term side effects of high-dose radioiodine therapy for thyroid carcinoma.
    Alexander C; Bader JB; Schaefer A; Finke C; Kirsch CM
    J Nucl Med; 1998 Sep; 39(9):1551-4. PubMed ID: 9744341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life with well-differentiated thyroid cancer: treatment toxicities and their reduction.
    Mendoza A; Shaffer B; Karakla D; Mason ME; Elkins D; Goffman TE
    Thyroid; 2004 Feb; 14(2):133-40. PubMed ID: 15068628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sialoadenitis following ablative therapy with high doses of radioiodine for treatment of differentiated thyroid cancer].
    Rosário PW; Maia FF; Barroso A; Padrão EL; Rezende L; Purisch S
    Arq Bras Endocrinol Metabol; 2004 Apr; 48(2):310-4. PubMed ID: 15640888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sialadenitis after radioiodine therapy. Analysis of factors that influence the response to medical treatment.
    Geres AE; Mereshian PS; Fernández S; Rey Caro DG; Castro R; Podio R; Ojeda S
    Endocrinol Nutr; 2015 Dec; 62(10):493-8. PubMed ID: 26459118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sodium-iodine symporter and the proton-pump inhibitors in - related to the side effects of- the treatment of thyroid cancer with iodine-131.
    Sfakianakis G; Sfakianaki E
    Hell J Nucl Med; 2007; 10(1):2-5. PubMed ID: 17450241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary gland protection with sialagogues: a case study.
    Van Nostrand D; Atkins F; Bandaru VV; Chennupati SP; Moreau S; Burman K; Wartofsky L
    Thyroid; 2009 Sep; 19(9):1005-8. PubMed ID: 19500022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of selenium supplementation for protection of salivary glands from iodine-131 radiation damage in patients with differentiated thyroid cancer.
    Son H; Lee SM; Yoon RG; Lee H; Lee I; Kim S; Chung WY; Lee JW
    Hell J Nucl Med; 2017; 20(1):62-70. PubMed ID: 28315910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sialadenitis following radioiodine therapy - a new diagnostic and treatment modality.
    Nahlieli O; Nazarian Y
    Oral Dis; 2006 Sep; 12(5):476-9. PubMed ID: 16910918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interventional sialendoscopy for treatment of radioiodine-induced sialadenitis.
    Bomeli SR; Schaitkin B; Carrau RL; Walvekar RR
    Laryngoscope; 2009 May; 119(5):864-7. PubMed ID: 19266587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.
    Jarzab B; Handkiewicz-Junak D; Wloch J
    Endocr Relat Cancer; 2005 Dec; 12(4):773-803. PubMed ID: 16322322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sialoendoscopic treatment for radioiodine induced sialadenitis.
    Kim JW; Han GS; Lee SH; Lee DY; Kim YM
    Laryngoscope; 2007 Jan; 117(1):133-6. PubMed ID: 17202942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of reserpine on salivary gland radioiodine uptake in thyroid cancer.
    Levy HA; Park CH
    Clin Nucl Med; 1987 Apr; 12(4):303-7. PubMed ID: 3581610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptomatic late-onset sialadenitis after radioiodine therapy in thyroid cancer.
    An YS; Yoon JK; Lee SJ; Song HS; Yoon SH; Jo KS
    Ann Nucl Med; 2013 May; 27(4):386-91. PubMed ID: 23389626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of saliva in oral health: strategies for prevention and management of xerostomia.
    Brosky ME
    J Support Oncol; 2007 May; 5(5):215-25. PubMed ID: 17564151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salivary gland injury resulting from exposure to radioactive iodine: case reports.
    Mandel L; Liu F
    J Am Dent Assoc; 2007 Dec; 138(12):1582-7. PubMed ID: 18056102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sialoendoscopy: a viable treatment for I(131) induced sialoadenitis.
    De Luca R; Vicidomini A; Trodella M; Tartaro G; Colella G
    Br J Oral Maxillofac Surg; 2014 Sep; 52(7):641-6. PubMed ID: 24894709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of radioactive iodine therapy on parotid gland function.
    Maier H; Bihl H
    Acta Otolaryngol; 1987; 103(3-4):318-24. PubMed ID: 3495094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.